Assistant Professor, Harvard Medical School; Investigator, Brigham and Women's Hospital; Director of Gene Editing, Mass General Brigham Gene and Cell Therapy Institute; Associate Member, Broad Institute.

Omar Abudayyeh is an Assistant Professor at Harvard Medical School and an Investigator at Brigham and Women's Hospital, where he directs the Abudayyeh-Gootenberg lab developing next-generation gene editing, gene delivery, and synthetic biology technologies using protein engineering and AI. His lab builds virtual models of biological systems, spanning DNA, proteins, cells, and humans, to accelerate scientific discovery and drug development and to advance the understanding of aging and rejuvenation. He earned his Ph.D. in Feng Zhang's lab researching novel CRISPR enzymes for genome editing, therapeutics, and diagnostics, and has co-founded several gene editing and AI-bio companies.

Washington University in St.Louis School of Medicine, Dept of Pathology & Immunology

Maxim N Artyomov (PhD, MIT 2009) has been running Systems Immunology lab at Washington University in St. Louis since 2012. His integrated wetlab-drylab laboratory spans all aspects of systems immunology from molecular and cellular immunology to "omics" techniques for profiling and downstream analysis and focuses on the questions of immune aging and immunometabolism.

Northeastern University

Albert-László Barabási is a Distinguished University Professor at Northeastern University, where he directs the Center for Complex Network Research, with additional appointments at Harvard Medical School and Central European University. His research focuses on complex networks and network medicine, with applications to biology, aging, and human health. He is the author of Linked, Bursts, and The Formula, a member of the U.S. National Academy of Sciences and several other national academies, and has received honors including the Lilienfeld Prize, the John von Neumann Medal, and multiple honorary doctorates.

Director, Swiss Campus for Healthy Longevity, University of Basel

Prof. Bischoff-Ferrari is Director of the Swiss Campus for Healthy Longevity and Coordinator of the Global Health Span Extension Consortium. She is experienced in coordinating large translational research networks, including the European 5-country DO-HEALTH consortium and the Global Health Span Extension Consortium.

Gordian Biotechnology

Martin Borch Jensen is the cofounder and CSO of Gordian Biotechnology, which systemically generates causal atlases of pathophysiology to find treatments for age-related disease, and founder of Norn Group, a non-profit dedicated to accelerating progress in longevity.

MIT

Ed Boyden is Y. Eva Tan Professor in Neurotechnology at MIT, an investigator at the MIT McGovern Institute and the Yang Tan Collective, and professor of Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering at MIT. He leads the Synthetic Neurobiology Group, which develops technologies for analyzing and repairing the brain, and co-founded the Mindspan Institute in 2026 to advance large-scale human brain analysis.

Wellcome Leap Dynamic Resilience program; Department of Biochemistry, University of Oxford

Lynne Cox is the Program Director of Wellcome Leap's Dynamic Resilience global research program, which aims to identify biomarkers and mechanisms of resilience and evaluate them in clinical studies to reduce frailty. She is also Professor of Geroscience at the University of Oxford, where her research focuses on cellular senescence and geroprotective interventions.

Gero and NUS (Singapore)

Peter Fedichev is a physicist-turned-biotech entrepreneur, Co-founder & CEO of Gero, a company applying physics-informed AI and large-scale human data to discover therapies that slow aging and treat age-related diseases. His research focuses on quantitative models of aging, biomarkers across species, and novel physical concepts underlying aging.

Harvard Medical School

Dr. Vadim Gladyshev is a Professor of Medicine at Harvard Medical School and Director of Redox Medicine at Brigham & Women's Hospital. His research focuses on aging clocks and other biomarkers of biological age, advancing the understanding and measurement of the aging process.

University of Rochester

Vera Gorbunova is an endowed Professor of Biology at the University of Rochester and a director of the Rochester Aging Research Center and of Nathan Shock Center of Excellence in aging research. Her research is focused on understanding the mechanisms of longevity and genome stability and on the studies of exceptionally long-lived mammals.

Allen Institute

Claire Gustafson, Ph.D. is an Assistant Investigator at the Allen Institute, where she leads research focused on understanding normal human immunity across the lifespan. Her group utilizes high-dimensional multi-omics and novel model systems to uncover mechanisms of immune homeostasis, infection, vaccination responses, and immune aging, including development of the Human Immune Health Atlas.

University of California, Los Angeles

Steve Horvath is Professor of Medicine in the Division of Geriatrics at the David Geffen School of Medicine, UCLA, and Director of Aging Biology Research in the Department of Medicine. His research centers on epigenetic biomarkers of aging; he developed the epigenetic clock and related DNA methylation-based age estimators used widely in aging research, and he founded the non-profit Epigenetic Clock Development Foundation.

Tufts University

Dr. Michael Levin is the Vannevar Bush Distinguished Professor of Biology at Tufts University and Director of the Allen Discovery Center. His research explores how cells communicate to create complex anatomical structures, focusing on bioelectricity in development, regeneration, and cancer, and advancing regenerative biology through innovations including Xenobots and Anthrobots.

Professor João Pedro de Magalhães, Genomics of Ageing and Rejuvenation Lab, Department of Inflammation and Ageing, College of Medicine and Health, University of Birmingham, UK Prof de Magalhães leads the Genomics of Ageing and Rejuvenation Lab at the University of Birmingham.

Prof de Magalhães leads the Genomics of Ageing and Rejuvenation Lab at the University of Birmingham. His lab integrates genomics, machine learning, and experimental biology to study aging and develop interventions that delay age-related diseases and improve human health. He also serves as Chief Scientific Officer of YouthBio Therapeutics, developing rejuvenation gene therapies.

Brigham and Women's Hospital, and Harvard Medical School

Samantha Morris is an Associate Professor of Medicine at Harvard Medical School and Principal Investigator at Brigham and Women's Hospital. Her laboratory develops and applies functional single-cell genomic technologies to understand how gene regulatory networks control cell fate decisions in development, regeneration, aging, and disease. By combining lineage tracing, transcription factor recording, and computational modeling, her group seeks to uncover the regulatory principles that govern cell identity and enable cell fate engineering.

University of California, Los Angeles

Dr. Rando is the Director of the Broad Stem Cell Research Center at UCLA where he is a professor of Neurology and Molecular, Cell, and Developmental Biology. His lab has been a leader in stem cell biology and aging, pioneering the use of heterochronic parabiosis to study molecular, cellular, and organismal aging.

Buck Institute

Dr. Birgit Schilling works at the Buck Institute for Research on Aging in the San Francisco Bay Area since 2000, where she leads her own laboratory as Professor and serves as Director of the Mass Spectrometry and Proteomics Technology Center. Her research focuses on proteomics, biomarker discovery, and translational approaches to improve aging and age-related diseases.

University of California, Irvine

Dr. Vittorio Sebastiano is a Full Professor in the Department of Biological Chemistry at the University of California, Irvine, and Adjunct Professor of Obstetrics and Gynecology at Stanford University School of Medicine. He is internationally recognized for his pioneering contributions to regenerative medicine, cellular reprogramming, reproductive biology, and the biology of aging.

Stanford School of Medicine

Dr. Michael Snyder is the Stanford W. Ascherman Professor and Director of the Center for Genomics and Personalized Medicine at Stanford University. Dr. Snyder's innovative work utilizes big data generated through high-throughput technologies, including genomics, proteomics, and wearable devices, to monitor disease onset and progression in real time as well as aging.

Brigham and Women’s Hospital and Harvard Medical School

Dr. Alexander Tyshkovskiy is an Investigator at Brigham and Women's Hospital and an Instructor in Medicine at Harvard Medical School. His research combines computational biology, machine learning, and comparative biology to identify conserved molecular signatures and mechanisms of aging and lifespan regulation across mammalian species.